These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1675404)

  • 1. Possible relation between restless legs and anaemia in renal dialysis patients.
    Roger SD; Harris DC; Stewart JH
    Lancet; 1991 Jun; 337(8756):1551. PubMed ID: 1675404
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Salvadeo A
    Nephron; 1992; 61(1):54-7. PubMed ID: 1528341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of recombinant human erythropoietin on synthesis of methylguanidine in uraemic patients on haemodialysis or continuous ambulatory peritoneal dialysis.
    Sasagawa I; Nakada T; Kubota Y; Sawamura T; Suzuki H; Hashimoto T
    Int Urol Nephrol; 1994; 26(6):701-5. PubMed ID: 7759207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased ultrafiltration after erythropoietin-induced correction of renal anemia in patients on continuous ambulatory peritoneal dialysis.
    Steinhauer HB; Lubrich-Birkner I; Dreyling KW; Hörl WH; Schollmeyer P
    Nephron; 1989; 53(1):91-2. PubMed ID: 2779711
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of renal anemia with recombinant human erythropoietin.
    Schaefer RM; Hörl WH; Massry SG
    Am J Nephrol; 1989; 9(5):353-62. PubMed ID: 2679093
    [No Abstract]   [Full Text] [Related]  

  • 6. Sleep Disorders, Restless Legs Syndrome, and Uremic Pruritus: Diagnosis and Treatment of Common Symptoms in Dialysis Patients.
    Scherer JS; Combs SA; Brennan F
    Am J Kidney Dis; 2017 Jan; 69(1):117-128. PubMed ID: 27693261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of recombinant human erythropoietin on growth hormone responses to growth hormone releasing hormone in uremic patients.
    Díez JJ; Iglesias P; Selgas R
    Clin Nephrol; 1994 Feb; 41(2):119. PubMed ID: 8004829
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of anaemia in CAPD patients with recombinant human erythropoietin.
    Ramello A; Malcangi U; Bruno M; Perosa P; Reina E; Rizzuto A; Nasini MG; Carozzi S
    Adv Perit Dial; 1990; 6():308-11. PubMed ID: 1982834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemia of hemodialysis patients: evaluation of the effect of BK-F polymethylmethacrylate membrane.
    Locatelli F; Andrulli S; Del Vecchio L
    Contrib Nephrol; 1999; 125():173-81. PubMed ID: 9895439
    [No Abstract]   [Full Text] [Related]  

  • 10. Subcutaneous erythropoietin in the treatment of renal anaemia.
    Drinovec J; Varl J
    Przegl Lek; 1992; 49(1-2):38-40. PubMed ID: 1455004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaemia correction--does the mode of dialysis matter?
    Sherman RA
    Nephrol Dial Transplant; 2001 May; 16(5):1076. PubMed ID: 11328923
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythropoietin escape in five CAPD patients.
    Williams P; Jones J
    Nephron; 1996; 73(2):354. PubMed ID: 8773387
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical definition of the uremic syndrome and possible therapeutic implications.
    Vanholder R; Hsu C; Ringoir S
    Artif Organs; 1993 Apr; 17(4):234-9. PubMed ID: 8498902
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of recombinant human erythropoietin (rh-EPO) in the treatment of anemia in hemodialysis patients: a multicenter Italian experience.
    Buccianti G; Colombi L; Battistel V
    Haematologica; 1993; 78(2):111-7. PubMed ID: 8349186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effect of erythropoietin on endothelin release in uremia.
    Nurol A; Bahattin A; Tolga K; Tekin A; Abdülkerim B
    Nephron; 1996; 72(4):728-9. PubMed ID: 8730461
    [No Abstract]   [Full Text] [Related]  

  • 16. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].
    Litwin M; Boguszewska-Baczkowska A; Jelonek A
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):135-6. PubMed ID: 8090665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin and peritoneal dialysis.
    Digenis GE; Yatzidis H
    Int J Artif Organs; 1990 Jun; 13(6):344-6. PubMed ID: 2199378
    [No Abstract]   [Full Text] [Related]  

  • 18. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
    Korbet SM
    Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
    [No Abstract]   [Full Text] [Related]  

  • 19. Correction of anemia using self-administered daily subcutaneous erythropoietin in uremic patients on continuous ambulatory peritoneal dialysis.
    Li PK; Leung CB; Lui SF; Leung JC; Shek AC; Lai KN
    Int J Artif Organs; 1993 Jul; 16(7):510-4. PubMed ID: 8370605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of correcting anemia with recombinant erythropoietin on the central hemodynamic indices of patients on regular hemodialysis].
    Ermolenko VM; Khvoĭnitskiĭ VA; Suprun EK; Tsukerman LI; Pokrovskiĭ IuA
    Ter Arkh; 1992; 64(7):86-8. PubMed ID: 1440377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.